Longeveron is a publicly listed company tracked for investment-relevant business developments.
Lomecel-B, a mesenchymal stem cell from young bone marrow, restores blood-brain barrier integrity, clears amyloid plaques, increases hippocampal volume, and reduces neuroinflammation in Alzheimer's patients, with potential preventative applications.